Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.

Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Huang VJ, Erlander MG, Brachtel EF, Dry SM.

Mod Pathol. 2014 Jan;27(1):44-54. doi: 10.1038/modpathol.2013.105. Epub 2013 Jul 12.

2.

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.

Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, Barshack I, Nass D, Tobar A, Feinmesser M, Rosenfeld N, Leizerman I, Ashkenazi K, Spector Y, Chajut A, Aharonov R.

Mod Pathol. 2010 Jun;23(6):814-23. doi: 10.1038/modpathol.2010.57. Epub 2010 Mar 26.

3.

Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer.

Kulkarni A, Pillai R, Ezekiel AM, Henner WD, Handorf CR.

Diagn Pathol. 2012 Aug 21;7:110. doi: 10.1186/1746-1596-7-110.

4.

Development and validation of a gene expression tumour classifier for cancer of unknown primary.

Tothill RW, Shi F, Paiman L, Bedo J, Kowalczyk A, Mileshkin L, Buela E, Klupacs R, Bowtell D, Byron K.

Pathology. 2015 Jan;47(1):7-12. doi: 10.1097/PAT.0000000000000194.

PMID:
25485653
5.

Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.

Bellizzi AM.

Adv Anat Pathol. 2013 Sep;20(5):285-314. doi: 10.1097/PAP.0b013e3182a2dc67. Review.

PMID:
23939147
6.

Efficient identification of miRNAs for classification of tumor origin.

Søkilde R, Vincent M, Møller AK, Hansen A, Høiby PE, Blondal T, Nielsen BS, Daugaard G, Møller S, Litman T.

J Mol Diagn. 2014 Jan;16(1):106-15. doi: 10.1016/j.jmoldx.2013.10.001. Epub 2013 Nov 5.

PMID:
24211363
7.

Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary

Chauhan A, Farooqui Z, Silva SR, Murray A, Hodges KB, Yu Q, Myint ZW, Raajesekar AK, Weiss H, Arnold S, Evers BM, Anthony L.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):113-116.

8.

Gene expression profiles help identify the tissue of origin for metastatic brain cancers.

Wu AH, Drees JC, Wang H, VandenBerg SR, Lal A, Henner WD, Pillai R.

Diagn Pathol. 2010 Apr 26;5:26. doi: 10.1186/1746-1596-5-26.

9.

A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors.

Maxwell JE, Sherman SK, Stashek KM, O'Dorisio TM, Bellizzi AM, Howe JR.

Surgery. 2014 Dec;156(6):1359-65; discussion 1365-6. doi: 10.1016/j.surg.2014.08.008. Epub 2014 Nov 11.

10.

Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier.

Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Singh V, Carey B, Erlander MG, Highsmith WE, Dry SM, Brachtel EF.

Clin Cancer Res. 2012 Jul 15;18(14):3952-60. doi: 10.1158/1078-0432.CCR-12-0920. Epub 2012 May 30.

11.

Classification of low-grade neuroendocrine tumors of midgut and unknown origin.

Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB, Van Velthuysen ML.

Hum Pathol. 2002 Nov;33(11):1126-32.

PMID:
12454818
12.

An integrated tool for determining the primary origin site of metastatic tumours.

Santos MTD, Souza BF, Cárcano FM, Vidal RO, Scapulatempo-Neto C, Viana CR, Carvalho AL.

J Clin Pathol. 2018 Jul;71(7):584-593. doi: 10.1136/jclinpath-2017-204887. Epub 2017 Dec 16.

13.

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

Hainsworth JD, Rubin MS, Spigel DR, Boccia RV, Raby S, Quinn R, Greco FA.

J Clin Oncol. 2013 Jan 10;31(2):217-23. doi: 10.1200/JCO.2012.43.3755. Epub 2012 Oct 1.

PMID:
23032625
14.

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.

Talantov D, Baden J, Jatkoe T, Hahn K, Yu J, Rajpurohit Y, Jiang Y, Choi C, Ross JS, Atkins D, Wang Y, Mazumder A.

J Mol Diagn. 2006 Jul;8(3):320-9.

15.

Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets.

Faruki H, Mayhew GM, Fan C, Wilkerson MD, Parker S, Kam-Morgan L, Eisenberg M, Horten B, Hayes DN, Perou CM, Lai-Goldman M.

Arch Pathol Lab Med. 2016 Jun;140(6):536-42. doi: 10.5858/arpa.2015-0113-OA. Epub 2015 Oct 2.

PMID:
26430809
16.

Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Monzon FA, Medeiros F, Lyons-Weiler M, Henner WD.

Diagn Pathol. 2010 Jan 13;5:3. doi: 10.1186/1746-1596-5-3.

17.

Genomic landscape of pancreatic neuroendocrine tumors.

Gebauer N, Schmidt-Werthern C, Bernard V, Feller AC, Keck T, Begum N, Rades D, Lehnert H, Brabant G, Thorns C.

World J Gastroenterol. 2014 Dec 14;20(46):17498-506. doi: 10.3748/wjg.v20.i46.17498.

18.

Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.

Joosse SA, Brandwijk KI, Devilee P, Wesseling J, Hogervorst FB, Verhoef S, Nederlof PM.

Breast Cancer Res Treat. 2012 Apr;132(2):379-89. doi: 10.1007/s10549-010-1016-7. Epub 2010 Jul 8.

PMID:
20614180
19.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Horlings HM, van Laar RK, Kerst JM, Helgason HH, Wesseling J, van der Hoeven JJ, Warmoes MO, Floore A, Witteveen A, Lahti-Domenici J, Glas AM, Van't Veer LJ, de Jong D.

J Clin Oncol. 2008 Sep 20;26(27):4435-41. doi: 10.1200/JCO.2007.14.6969.

PMID:
18802156
20.

Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.

Loudig O, Brandwein-Gensler M, Kim RS, Lin J, Isayeva T, Liu C, Segall JE, Kenny PA, Prystowsky MB.

Hum Pathol. 2011 Dec;42(12):1911-22. doi: 10.1016/j.humpath.2011.02.011. Epub 2011 Jun 17.

PMID:
21683979

Supplemental Content

Support Center